Skip to content
3 Questions with a MacArthur 'Genius' Drug Prices
3 Questions with a MacArthur Genius’
Q&A
How Medicare Drug Price Negotiations Finally Became Law Drug Prices
How Medicare Drug Price Negotiations Finally Became Law
Q&A
3 Ways Drug Pricing Reforms in Congress Will Help People Drug Prices
3 Ways Drug Pricing Reforms in Congress Will Help People
High Brand-Name Net Prices — and List Prices — Support Reforms to Medicare Part D Drug Prices
High Brand-Name Net Prices — and List Prices — Support Reforms to Medicare Part D
Medicare Negotiation Hearing: 3 Key Takeaways Drug Prices
Medicare Negotiation Hearing: 3 Key Takeaways
A New Generation in the Fight for Fair Drug Prices Drug Prices
A New Generation in the Fight for Fair Drug Prices
Q&A
A New Way to Begin the End of HIV in the U.S. Drug Prices
A New Way to Begin the End of HIV in the U.S.
Q&A
Congress: Pharma's Price Gouging is Purposeful Drug Prices
Congress: Pharma’s Price Gouging is Purposeful
Maximizing Opportunity, Minimizing Injustice for Our Nation’s Veterans Drug Prices
Maximizing Opportunity, Minimizing Injustice for Our Nation’s Veterans
Drug Pricing Reform Failure is Unacceptable Drug Prices
Drug Pricing Reform Failure is Unacceptable
Op-Ed
Part 3: After a Groundswell of Success in 2021, Stage is Set for Broader Rx Reform in 2022 Drug Prices
Part 3: After a Groundswell of Success in 2021, Stage is Set for Broader Rx Reform in 2022
Drug Affordability
Part 2: In Quest to Lower Rx Prices, States Deploy New Tools Drug Prices
Part 2: In Quest to Lower Rx Prices, States Deploy New Tools
Drug Affordability
Part 1: As Congress Debates Lowering Drug Prices, States Waste No Time Drug Prices
Part 1: As Congress Debates Lowering Drug Prices, States Waste No Time
Drug Affordability
Biden Takes Aim at Drug Prices with Executive Order. Does it Go Far Enough? Drug Prices
Biden Takes Aim at Drug Prices with Executive Order. Does it Go Far Enough?
MACPAC Recommends Policies To Reduce Spending on High Cost Specialty Drugs in the Medicaid Program Drug Prices
MACPAC Recommends Policies To Reduce Spending on High Cost Specialty Drugs in the Medicaid Program
'We Have a Problem': New Alzheimer’s Treatment Reflects Dysfunctional U.S. Drug Market Drug Prices
We Have a Problem’: New Alzheimer’s Treatment Reflects Dysfunctional U.S. Drug Market
‘It’s Just Simply the Cost Per Dose That Americans Are Being Charged More For’ Drug Prices
It’s Just Simply the Cost Per Dose That Americans Are Being Charged More For’
Q&A
Congress Grills Major Drug Manufacturer on Anticompetitive Tactics and Price Gouging Drug Prices
Congress Grills Major Drug Manufacturer on Anticompetitive Tactics and Price Gouging
President Biden Called on Congress to Lower Drug Prices. What’s Next? Drug Prices
President Biden Called on Congress to Lower Drug Prices. What’s Next?
New Laws Take Aim at Drug Prices, But Stronger Action Needed Drug Prices
New Laws Take Aim at Drug Prices, But Stronger Action Needed
After Sluggish Start, Is the Biosimilar Market Poised for Growth? Drug Prices
After Sluggish Start, Is the Biosimilar Market Poised for Growth?
Drug Pricing Reform Enters a Big, New Battleground: States Drug Prices
Drug Pricing Reform Enters a Big, New Battleground: States
Landmark SCOTUS Ruling Opens the Door for Stronger State Regulation of PBMs Drug Prices
Landmark SCOTUS Ruling Opens the Door for Stronger State Regulation of PBMs
A Drug is 90 Percent Effective at Preventing HIV. It Costs Up to $1,800 Per Month. Drug Prices
A Drug is 90 Percent Effective at Preventing HIV. It Costs Up to $1,800 Per Month.

About Us

We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
Arnold Ventures logo